Novartis on Track for Record High Close — Data Talk
Novartis AG Sponsored ADR (NVS) is currently at $108.68, up $0.55 or 0.51%
--Would be new all-time high (Based on available data back to Dec. 24, 1996)
--Would be the first record close since Jan. 22, 2024, when it closed at $108.47
--Currently up four of the past five days
--Currently up three consecutive days; up 2.1% over this period
--Best three day stretch since the three days ending June 6, 2024, when it rose 3.28%
--Up 2.09% month-to-date
--Up 7.64% year-to-date
--Up 18.95% from 52 weeks ago (July 10, 2023), when it closed at $91.36
--Would be a new 52-week closing high
--Up 18.95% from its 52-week closing low of $91.36 on July 10, 2023
--Traded as high as $108.75; highest intraday level since Jan. 22, 2024, when it hit $108.78
--Up 0.57% at today's intraday high
All data as of 9:54:01 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
July 08, 2024 10:12 ET (14:12 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks